J. Larrubia

发表

Role of T cell death in maintaining immune tolerance during persistent viral hepatitis.

D. Subirá, J. Míquel, M. Lokhande, 2013, World journal of gastroenterology.

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.

D. Vergani, A. King, G. Ogg, 1999, Gastroenterology.

Model to predict on‐treatment restoration of functional HBV‐specific CD8 + cell response foresees off‐treatment HBV control in eAg‐negative chronic hepatitis B

J. Míquel, M. Torralba, J. Larrubia, 2022, Alimentary pharmacology & therapeutics.

Undetectable HCV‐RNA at treatment‐week 8 results in high‐sustained virological response in HCV G1 treatment‐experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

A. Mangia, X. Forns, P. Maisonneuve, 2015, Journal of viral hepatitis.

According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity

D. Subirá, A. Olveira, J. García-Samaniego, 2017, Journal of Virology.

Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history

J. Míquel, J. Larrubia, E. Sanz-de-Villalobos, 2020, World journal of hepatology.

Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control

J. Míquel, J. Larrubia, E. Sanz-de-Villalobos, 2015 .

Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.

J. Míquel, J. Larrubia, E. Sanz-de-Villalobos, 2015, World journal of gastroenterology.

Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection.

M. Calvino, S. Albertos, J. Míquel, 2011, Cellular immunology.

HCV-specific CD8+ cell detection at week 12 of chronic hepatitis C treatment with PEG-interferon-α2b/ribavirin correlates with infection resolution.

J. Míquel, M. Lokhande, J. Larrubia, 2013, Cellular immunology.

Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.

M. Calvino, J. Larrubia, E. Sanz-de-Villalobos, 2008, World journal of gastroenterology.

Occult hepatitis B virus infection: a complex entity with relevant clinical implications.

J. Larrubia, 2011, World journal of gastroenterology.

1 HBV & HCV Immunopathogenesis

J. Míquel, M. Lokhande, J. Larrubia, 2012 .

HBV & HCV Immunopathogenesis

J. Míquel, M. Lokhande, J. Larrubia, 2011 .

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

Antonio Bertoletti, Graham S. Ogg, Carlo Ferrari, 2000 .

The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection

D. Vergani, A. King, G. Ogg, 2000, The Journal of experimental medicine.

Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment

R. Mena, A. Olveira, J. García-Samaniego, 2019, World journal of gastroenterology.

Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?

J. Míquel, J. Larrubia, Julia Peña-Asensio, 2018, World journal of gastroenterology.

Cytokines - their pathogenic and therapeutic role in chronic viral hepatitis.

J. Larrubia, E. Sanz-de-Villalobos, T. Parra, 2009, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[Acute pancreatitis induced by isoniazid, a casual association].

J. Mendoza, M. Díaz‐Rubio, D. Espinós, 1998, Anales de medicina interna.

Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma

J. Míquel, M. Torralba, J. Larrubia, 2021, Cancers.

Adaptive immune response during hepatitis C virus infection.

J. Míquel, M. Lokhande, J. Larrubia, 2014, World journal of gastroenterology.

Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.

M. Calvino, J. Míquel, J. Larrubia, 2009, World journal of gastroenterology.

Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

J. Larrubia, E. Moreno-Cubero, 2016, World journal of gastroenterology.

Mast cell quantification in normal peritoneum and during peritoneal dialysis treatment.

J. Jimenez-Heffernan, R. Selgas, M. Bajo, 2009, Archives of pathology & laboratory medicine.

The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.

M. Calvino, J. Larrubia, S. García-Garzón, 2007, Journal of hepatology.

Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis C

J. Míquel, M. Torralba, J. Larrubia, 2021, Cells.

Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

M. Buti, X. Forns, J. Calleja, 2015, Liver international : official journal of the International Association for the Study of the Liver.

The role of sonography in the early diagnosis of biliopancreatic Ascaris infestation.

M. Díaz‐Rubio, J. Ladero, J. Larrubia, 1996, Journal of clinical gastroenterology.

Persistent hepatitis C virus (HCV) infection impairs HCV‐specific cytotoxic T cell reactivity through Mcl‐1/Bim imbalance due to CD127 down‐regulation

J. Míquel, M. Lokhande, J. Larrubia, 2013, Journal of viral hepatitis.

Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Multicentre Cohort: Real-Life Experience From Spain

P. Geijo, M. Torralba, J. Larrubia, 2023, The Annals of pharmacotherapy.

HBsAg level defines different clinical phenotypes of HBeAg(−) chronic HBV infection related to HBV polymerase-specific CD8+ cell response quality

J. Larrubia, E. Sanz-de-Villalobos, Julia Peña-Asensio, 2024, Frontiers in immunology.